文献速递心脏核医学肿瘤 PET/CT

18F-FDG与18F-NaF PET作为2型糖尿病患者全身动脉粥样硬化进展标志物的纵向描述性影像研究

[18F]FDG and [18F]NaF as PET markers of systemic atherosclerosis progression: A longitudinal descriptive imaging study in patients with type 2 diabetes mellitus.
PubMed 文献 · J Nucl Cardiol · 2021-09-13

随访平均TBR[18F-NaF]与ΔCP评分及基线和随访CP评分正相关。结论提示全身动脉炎症是动脉微钙化发展的重要致病因素。

要点

  • 18F-NaF平均TBR与CP评分%变化和PWV无关。

核心结论

  • 概念验证研究提示全身动脉炎症是全身动脉微钙化发展的重要致病因素。

研究设计与样本

  • 比较基线18F-FDG PET/LDCT与5年随访18F-NaF PET/LDCT扫描。
  • 全身活性以平均靶本比(meanTBR)表示,即十支动脉SUVmax除以腔静脉SUVmean。
  • CT评估的大钙化以钙化斑块(CP)评分视觉评分;动脉僵硬度以颈股脉搏波速度(PWV)评估。

主要发现

  • meanTBR[18F-NaF]与CP评分%变化和PWV无关。

临床怎么用

  • 在早期2型糖尿病患者中,18F-FDG PET显示的动脉炎症可能预示后续18F-NaF PET显示的动脉微钙化进展。
  • 18F-NaF PET可用于评估与CT钙化评分相关的动脉微钙化负荷。

局限性

  • 基线使用18F-FDG而随访使用18F-NaF,两种PET标记未在同一时间点重复测量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: While [18F]-fluordeoxyglucose ([18F]FDG) uptake is associated with arterial inflammation, [18F]-sodium fluoride ([18F]NaF) is a marker for arterial micro-calcification. We aimed to investigate the prospective correlation between both PET markers over time and whether they are prospectively ([18F]FDG) and retrospectively ([18F]NaF) related to progression of systemic arterial disease in a longitudinal study in patients with type 2 diabetes mellitus (T2DM). METHODS: Baseline [18F]FDG PET/Low Dose (LD) Computed Tomography (CT) scans of ten patients with early T2DM without cardiovascular history (70% men, median age 63 years) were compared with five-year follow-up [18F]NaF/LDCT scans. Systemic activity was expressed as mean target-to-background ratio (meanTBR) by dividing the maximal standardized uptake value (SUVmax) of ten arteries by SUVmean of the caval vein. CT-assessed macro-calcifications were scored visually and expressed as calcified plaque (CP) score. Arterial stiffness was assessed with carotid-femoral pulse wave velocity (PWV). Five-year changes were expressed absolutely with delta (Δ) and relatively with %change. RESULTS: Baseline meanTBR[18F]FDG was strongly correlated with five-year follow-up meanTBR[18F]NaF (r = 0.709, P = .022). meanTBR[18F]NaF correlated positively with ΔCPscore, CPscore at baseline, and follow-up (r = 0.845, P = .002 and r = 0.855, P = .002, respectively), but not with %change in CPscore and PWV. CONCLUSION: This proof-of-concept study demonstrated that systemic arterial inflammation is an important pathogenetic factor in systemic arterial micro-calcification development.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Reijrink M, de Boer SA, Te Velde-Keyzer CA, et al. [18F]FDG and [18F]NaF as PET markers of systemic atherosclerosis progression: A longitudinal descriptive imaging study in patients with type 2 diabetes mellitus. J Nucl Cardiol. 2021. PMID: 34519008. doi:10.1007/s12350-021-02781-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。